Summary: A radioimmunoassay for the measurement of 3,3'-diiodo-L-thyronine (rT 2 ) in serum and amniotic fluid is described. Specific antisera to rT 2 were produced by immunization of rabbits with rT 2 conjugated to bovine serum albumin. The molar cross-reactivity tested for various iodothyronines and iodotyrosines was 0.3 % for triiodothyronine and 0.001 % for thyroxine. The sensitivity of the assay with a detection limit of 1.8 fmol/tube (0.94 pg/tube) was due to the high avidity of the antiserum and the use of 125 I-labelled rT 2 of maximum specific radioactivity. In most of 45 normal subjects, serum rT 2 levels measured in evaporated ethanol extracts were below the detection limit of 0.018 nmol/1. Mean rT 2 concentrations were 0.21 nmol/1 in newborn cord serum and 0.10 nmol/1 in amniotic fluid at 12 to 30 weeks of pregnancy. The molar concentration ratio of 3,3',5'-triiodothyronine (rT 3 ) to rT 2 was estimated to be 15.7 in cord serum of newborn. A similar rT 3 /rT 2 ratio was found in adults after intravenous application of 500 Atg rT 3 . Using these data and the known rT 3 values, a hypothetical mean serum rT 2 concentration in adult normal subjects of 0.015 nmol/1 was calculated. The radioimmunoassay described may be a useful analytical tool in studies of the synthesis as well as the metabolism of thyroid hormones.
Introduction
The availability of radioimmunolpgical methods for the development of sensitive radioimmunoassays for 3,3',5'-routine estimation of the thyroid hormones, triiodotriiodothyronine (reverse T 3 , rT 3 ) (1 , 2) have resulted in thyronine (fa) 1 and thyroxine (d), and the recent an intensification of studies on the peripheral conversion --·-of T 4 by monodeiodination. From these studies a serieŝ Abbreviations: rT 2 (3, 4) and more recently on the peripheral generation of rT 3 from T 4 (5, 6) have become available. These kinetic studies as well as recent investigations regarding the thyroidal formation of iodothyronines (7) have stimul ated interest in analytical methods for the quantitative determination of a further deiodination product of T 4 , i. e. 3,3'-diiodothyronine (rT 2 ).
This paper describes the methodology of a radioimmunoassay for rT 2 as well as its application for rT 2 determinations in serum and amniotic fluid. Preliminary results have been reported elsewhere (8) . In the course of the development of this method, two papers as abstracts were published regarding a rT 2 radioimmunoassay. Chopra et al. (9) applied a rT 2 radioimmunoassay to the measurement of the in-vitro deiodination of T 3 and rT 3 added to liver homogenates. Earl et al. (10) investigated the extrathyroidal formation of rT 2 in athyreotic patients receiving high doses of T 4 over a long period. At present no quantitative data are available concerning the natural existence of rT 2 in man.
Materials and Methods

Antisera
Antisera to 1X2 were produced in three rabbits immunized by serial injections of a conjugate of rT 2 to bovine serum albumin in complete Freund^ adjuvant as described earlier for raising antibodies to T3 and T 4 (11, 12) . All immunized rabbits produced antisera satisfactory for radioimmunoassay of rT 2 . The antiserum selected for use in the studies to be described was obtained after three injections of the immunogen, eight weeks after starting immunization. It was used in a final dilution of 1:180 000 in an incubation volume of 600 μΐ.
The rT 2 conjugate to bovine serum albumin, all iodothyronines and iodotyrosines used in this study were obtained by courtesy of Henning Berlin GmbH.
Preparation of 12S I-labelled rT 2 Labelled rT 2 of maximum specific radioactivity was obtained by radioiodination. of 3-iodo-L-thyronine with chloramin T. 3-io4o-irthyronine was dissolved in 0.01 mpl/1 sodium hydroxide, chloramin T (Merck, Darmstadt) and sodium disulfite in Q.I mql/l phosphate buffer pH 7,0. For labelling, 10 μΐ volumina of the following reagents were pipetted into a microflex vial (Radiochemical Centre, Amersham) containing 40 μΐ 0.5 mol/l phosphate buffer pH 7.5:37 MBq (1 mCi) 125 Iodine (approximately 0.5 nmol iodine, Radiochemical Centre, Amersham), 2 nmol 3-iodo-i-thyronine, 0.2 μιηοΐ chloramin T. After an incubation period of 30 s, 1.5 μπιοί sodium disulfite were added. The reaction mixture was transferred to a paper strip (Whatman 3MM; 3 cm X 56 cm) and the labelled reaction products were separated by descending preparative paper chrorriatography using iso-amylalcohol:n-hexane:2 mol/l ammonia (volumes, 50 ml + 10 ml + 60 ml) as elution system (13) . The radioactivity distribution along the paper strip was estimated using a paper and thin-layer scanner (D nnschichtscanner II, Berthold, Wildbad). The paper segment corresponding to the 125 l-rT 2 peak was cut out and the labelled compound was eluted with methanol containing 0.25% concentrated ammonia. This solution was stored at -20 °C. the radio chemical.purity was tested by thin-layer chromatography (silica gel 60 F 2 s4 plates, Merck) in ethyl acetate:methanol:3 mol/l ammonia (volumes, 50 ml + 20 ml + 10 ml). For use in the assay, the methanol-ammonia eluate of labelled rT 2 was directly diluted with barbital buffer.
Preparation of test samples Serum and amniotic fluid samples were extracted with two parts of ethanol. 300 μΐ ethanol extract, which were equivalent to 100 μΐ of original sample, were evaporated to dryness and used for rT 2 assay. The extraction yields were estimated to be 98.5% for serum and 100% for amniotic fluid. For recovery experiments, known amounts of un labe lied rT 2 were addded to serum, which was then extracted in the routine way. Enrichment of iodothyronines from serum was performed using an ion-ex change resins (standard II columns, Bio-Rad, M nchen). The columns were equilibrated with 3 ml 0.2 mol/l sodium hydroxide. 5 ml serum was hydrolysed with 5 ml 0.2 mol/l sodium hydroxide for 15 min and passed through the columns. The columns were then washed two times with 5 ml of a solution of isppropanol and sodium acetate (Bio-Rad), two times with 2.5 mol/l acetic acid and once with 0.5 ml glacial acetic acid. The iodothyronines were eluted with 3 ml of glacial acetic acid. The iodothyronine fraction was evaporated to dryness by an air stream and the residue redissolved in 1 ml barbital buffer. In this solution, tracer experiments yielded a mean recovery of 64% of added labelled rT 2 . 200 μΐ samples, which were equivalent to 1 ml of original serum, were pipetted for rT 2 assay. rT 2 -free serum samples prepared by charcoal extraction were run in each set of enrichment experiments to correct for blank effects.
Assay procedure The rT 2 assay was performed in 0.08 mol/l barbital buffer pH 8.6 containing 2 g/1 bovine serum albumin and 200 mg/1 sodium azide. Reagents were incubated as follows: Evaporated serum or amniotic fluid extract (representing 100 μΐ of original sample), or 100 μΐ standard solution (from 1.8 to 914 fmol, i. e. 0.94 to 480 pg rT 2 ), 100 μΐ tracer solution (containing 925 Bq (25 nCi) corresponding to approximately 6 pg 125 I-rT 2 and 0.5 μΐ normal rabbit serum), 100 μΐ antiserum to rT 2 diluted 1:30 000, and barbital buffer to give a final volume of 600 μΐ. After an incubation period of 1 to 3 hours at room temperature, 100 μΐ antirabbit gammaglobulin serum (donkey) were added and incubated at 4 °C over night. After centrifugati n, the precipitated radioactivity was measured. Corrections were made for non-specific binding which was usually between 1.5 and 2.5% of total activity. All measurements were performed in triplicate.
rT 3 measurements in serum and amniotic fluid were performed by a modification of our ιΊ$ radioimmunoassay pub shed previously (2) . rTa was directly estimated in 50 μΐ samples of serum or amniotic fluid after inhibition of serum binding proteins with 150 μg/tube and 100 μg/tube 8-anilino-l-naphthalene sulfonic acid in the case of serum and amniotic fluid, respectively. T 3 and T 4 were measured by radioimmunoassay as previously reported (11, 12) .
Results
Labelling
The paper chromatogram ( fig. 1) shows a clear separation of the two major labelled products: rT 2 with radioactive iodine in 3'-position and double labelled rT 3 Tab. 1. Relative molar cross-reactivity of iodothyronines and iodotyrosines in the rT2 radioimmunoassay. Scatchard plot analysis yielded an effective equilibrium constant (14) of 2 X 1Ö 10 1/mol. Due to this high avidity of the chosen antiserum, a highly sensitive rT 2 radioimmunoassay could be established. The lower limit of detection was 1.8 fmol/tube (0.94 pg/tübe). A 50% inhibition of labelled rT 2 bound to antibody was achieved with 85 to 95 fmol/tube rf 2 (45 to 50 pg/tube) in five successive assays.
The mean recovery of unläbelled rT 2 added to a normal serum pool in amounts ranging from 0.036 to 4.60 nmol/1 serum was 103% (range 92 to 112%). Intra-assay reproducibility was evaluated by ISfold determination of serum from a normal volunteer having received exogenous rT 2 for kinetic studies and was found to be 38.8 ±3.0 fmol/tube (coefficient of variation 7.8%). The mean inter-assay reproducibility of 6 samples in 5 successive assays (mean rT 2 between 56 und 148 fmol/tube) was 8.8% ranging from 5.6 to 14.5%.
Application to measurements in serum and amniotic fluid The radioimmunoassay was applied to rT 2 measurements in serum and amniotic fluid. Table 2 presents mean values and ranges of these estimates in serum of normal subjects, in arterial cord serum of newborn infants, and in amniotic fluid at early pregnancy stages. rT 3 values are also shown. Serum rT 2 measured in 45 normal subjects in three different assays was below the detection limit of 0.018 nmol/1 in approximately 80% of the collective. The upper range in sera with measurable rT 2 concentrations was 0.086 nmol/1 (0.045 jug/l). In biological fluids with high rT 3 levels clearly measurable rT 2 concentrations were found. The mean rT 2 value in 39 newborn cord sera was 0.211 nmol/1 (0.11 Mg/1). The mean rT 3 concentration of these samples (3.13 nmol/1) is approximately ten times higher than in serum of adult normal subjects. The mean rT 2 level in amniotic fluids at 12 to 30 weeks of pregnancy was found to be 0.100 nmol/1 (0.053 Mg/l). The mean rT 3 level in amniotic fluid of 3.21 nmol/1 is comparable with that in cord serum. T 3 and T 4 concentrations in amniotic fluid are very low (data not shown).
The mean value of molar rT 3 /rT 2 ratios in cord serum was calculated to be 15.7. The mean rT 3 /rT 2 ratio in amniotic fluid was 38.1 with single values showing a wide distribution between 3.0 and 86.
After tenfold enrichment of iodothyronines by anionexchange resins, we have found a mean rT 2 concentration of 0.074 nmol/1 (0.039 g/l) in five normal sera. rT 2 determination in the same non-enriched sera yielded rT 2 values slightly above the detection limit of 0.018 nmol/1. For control experiments, known amounts of unläbelled rT 2 were added to rT 2 -free serum and normal serum prior to enrichment. The recovery of rT 2 in these samples after enrichment was between 88 and 104%.
Preliminary results regarding the kinetics of rT 2 in man were obtained by the measurement of serum rT 2 after a bulk injection of 950 nmol (500 Mg) rT 2 intravenously. The curve in figure 3 demonstrates the disappearance of imrnunoassayable rT 2 from serum in one normal volunteer. A rapid rate of rT 2 elimination from serum within the first hour is followed by a constant disappearance rate up to 6 hours after injection. During this period rT 2 
10-'
Concentration of iodothyronines or iodotyrosines Imol/tubel tr tions after normalization to 70 kg body weight within 5 hours post rT 3 injection. The inset presents mean rT 3 /rT 2 ratios determined from the elimination curves. These ratios decrease rapidly from 92 to approximately 14 within 2 hours, then remain constant during the next 3 hours. The mean ± standard deviation of all single rT 3 /rT 2 ratios between 2 and 5 hours after injection was calculated to be 14.3 ± 2.2.
the linear part of the elimination curve, the halftime of rT 2 in serum was estimated to be 1.2 hours in that person.
In a further experiment 770 nmol (500 Mg) rT 3 were injected into three normal V luiiteers. Serum concentrations of rT 3 as well as that of rT 2 generated from rT 3 by peripheral deiodination were then measured by radiimmunoassay. Figure 4 shows rT 3 and rT 2 serum concen-
Discussion
The presence of rT 2 in thyroid tissue and plasma of rats was first reported by Roche et al. (15) in 1955. The method used in these early studies was based on the paper Chromatographie separation of in-vivo labelled iodothyronines after intravenous administration of l3l lodide in rats. Through the application of this techni-que it was found, that the relative rT 2 concentration in plasma was approximately 25 % of that of thyroxine. T 3 and rT 3 were detected in much lower concentrations. Although the existence of rT 2 in the thyroid gland of the rat could be confirmed (7), it appears that the reported value of the relative rT 2 concentration in rat plasma is erroneously high. This is probably due to artefacts in the two-dimensional paper chromatography. From kinetic studies with radioactive labelled rT 2 in man it was concluded that due to its extremely short biological halftime the presence of rT 2 in human serum would be very improbable (16) . As a result of these early studies it is evident that a direct quantitative determination of rT 2 in biological fluids is only possible by the use of a highly specific and highly sensitive analytical method. The radioimmunoassay for rT 2 described in this paper satisfies these criteria.
By the immunization of three rabbits with rT 2 conjugated to bovine serum albumin, antisera with high concentrations of antibodies to rT 2 were obtained in two animals, allowing final assay dilutions of 1:120 000 and 1:180 000, respectively. These high titres are comparable with that of antisera to T 3 obtained previously using the same immunization procedures (11), whereas immunizations with 14 (12) and rT 3 (2) conjugates to bovine serum albumin yielded antisera with titres tenfold lower. It seems likely that these differences in the immune response may be due to the presence of only one iodine atom in 3'-position in the case of rT 2 and T 3 , and the presence of two iodines at the outer phenolic ring in the T 4 and rT 3 molecule.
The highest cross-reactivity of the antiseruin used for rT 2 assay was observed for T 3 (0.31 %) reflecting again the above mentioned similarities between rT 2 and T 3 with respect to chemical structure. A very low crossreactivity was found for T 4 (0.001 %), which of all iodothyronine components in biological material is generally present in the highest concentration. Due to this low cross-reactivity the measurement of rT 2 in serum is not influenced by T 4 . In the same manner, the absence of cross-reactions with monoiodotyrosine and diiodotyrosine exclude any interference of rT 2 measurements in thyroid tissue by these compounds.
The high sensitivity of this rT 2 radioimmunoassay is a consequence of the high avidity of the antiserum and the use of labelled rT 2 with maximum specific radioactivity. We have found a twofold effective equilibrium constant of rT 2 antiserum in comparison to our rT 3 radioimmunoassay (2). The lower limit of detection and the 50% intercept are approximately half of that obtained in the rT 3 assay.
The finding that rT 2 measured by our method in unconcentrated serum samples was undetectable in most of normal subjects, confirm the earlier speculations of Stanbury & Morris (16) that serum rT 2 levels in man should be extremely low. In cord serum, however, clearly increased rT 2 levels with a mean value of 0.211 nmol/1 were found. Elevated rT 2 concentrations (mean 0.100 nmol/1) compared to serum levels of adult normal subjects were also observed in amniotic fluid at early pregancy stages. In both cord serum and amniotic fluid, extremely high rT 3 concentrations accompanied by reduced T 3 levels have been recently reported (17, 18, 19) .
The mean molar rT 3 /rT 2 ratio in cord serum was found to be 15.7. A similar ratio of 14.3 was observed in three normal volunteers 2 to 5 hours after application of 500 § rT 3 . In this experiment the rT 3 /rT 2 ratio decreased rapidly in the first 2 hours. This ratio remained constant after the rT 3 elimination curve showed a linear decrease, indicating the equilibration of rT 3 in its total distribution space. The comparability of the rT 3 /rT 2 ratio found in the kinetic experiment with that in cord serum suggest that the peripheral deiodination rate of rT 3 as well as the degradation rate of rT 2 are similar in normal persons and newborn infants. This conclusion enables the calculation of a hypothetical mean rT 2 concentration in normal subjects. Using the mean rT 3 concentration of 0.31 nmol/1 measured in our normal collective and a rT 3 /rT 2 ratio of about 15, one may calculate that the mean rT 2 level in serum of normal adults should be approximately 0.015 nmol/1, a value slightly below our detection limit.
On the other hand, a mean rT 2 value of 0.074 nmol/1 was measured in a limited number of normal sera after iodothyronine enrichment. Several factors may be responsible for this discrepancy. The accuracy of measurements near the detection limit of a radioimmunoassay is more or less influenced by protein interferences of individual test sera, by the quality of antigen-free serum and by other factors, even when ethanolic serum extracts were assayed. In the case of rT 2 -enriched test samples, it cannot be excluded that artefacts due to anion-exchange chromatography contribute to systematically elevated results. At present, it is therefore not possible to specify a reliable mean serum rT 2 level in adult normal subjects. From our results, however, it seems likely that this value should be lower than 0.1 nmol/1.
It is at the present time not clear whether rT 2 has any physiological relevance. Therefore the usefulness of the described method in clinical diagnostics is questionable. However, the possibility for the quantitative determination of rT 2 may be qf importance for the further clarification of peripheral thyroxine deiodination, especially in kinetic and in vitro experiments.
